Bioinformatics Market to Reach USD 29.1 Billion by 2031 at 12.8% CAGR; North America Leads with 41% Share - Key Players: Illumina, Thermo Fisher, QIAGEN

The Global Bioinformatics Market size reached USD 11.4 billion in 2022 and is projected to reach USD 29.1 billion by 2031, growing at a CAGR of 12.8% during the forecast period 2024-2031. The market has demonstrated strong and consistent growth in recent years, driven by the increasing volume of biological data generated from genomics, proteomics, and next-generation sequencing (NGS) technologies, along with rising investments in life sciences research and precision medicine.

The bioinformatics market is expanding rapidly due to its critical role in data storage, analysis, and interpretation for drug discovery, clinical diagnostics, and personalized healthcare. Advancements in artificial intelligence, machine learning, and cloud computing are significantly enhancing bioinformatics platforms, enabling faster and more accurate analysis of complex biological datasets. Additionally, growing applications in oncology, rare disease research, agricultural biotechnology, and vaccine development, coupled with strong support from government initiatives and academic research institutions, are further strengthening the global bioinformatics market outlook.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioinformatics-market?sai-v

Bioinformatics is the field that combines biology, computer science, and data analytics to collect, manage, analyze, and interpret biological and genomic data for research, diagnostics, and drug discovery.

Key Developments
✅ October 2025: Research institutions and clinical laboratories in North America used bioinformatics tools for analysis of genomic, transcriptomic, proteomic, and other biological data in research and diagnostic workflows.

✅ September 2025: European biotechnology and pharmaceutical organizations integrated bioinformatics platforms with laboratory information management systems (LIMS) to support data processing, interpretation, and storage.

✅ August 2025: Asia-Pacific academic and commercial research centers employed bioinformatics software for comparative genomics, variant calling, and biological pathway analysis.

✅ July 2025: Bioinformatics technology providers enhanced software solutions with improved algorithms, data visualization capabilities, and integration of multiple omics datasets.

✅ May 2025: Contract research organizations and life sciences companies used bioinformatics pipelines for drug discovery support, target identification, and preclinical data analysis.

✅ March 2025: Regulatory authorities reviewed compliance documentation and data governance practices for bioinformatics tools used in clinical and research applications.

Mergers & Acquisitions
✅ November 2025: A global life sciences software company acquired a bioinformatics solutions provider to expand its analytics and data management offerings.

✅ August 2025: A European bioinformatics firm partnered with a genomics services provider to integrate computational analysis capabilities into sequencing workflows.

✅ June 2025: An Asia-Pacific biotechnology company acquired a bioinformatics software developer to strengthen its data analysis and interpretation tools.

Key Players
Illumina Inc. | Thermo Fisher Scientific | QIAGEN N.V. | Agilent Technologies | PerkinElmer | Celera Corporation | Dassault Systèmes | Data4Cure | Geneva Bioinformatics SA | Lineage Cell Therapeutics | Others

Key Highlights
Illumina Inc. holds a share of 26.9 percent, driven by its dominance in next-generation sequencing platforms, extensive genomics data output, and strong integration of bioinformatics tools for large-scale genomic analysis.

Thermo Fisher Scientific accounts for 21.4 percent, supported by its comprehensive bioinformatics software, life sciences instrumentation, and strong adoption across research, clinical, and pharmaceutical applications.

QIAGEN N.V. captures 14.6 percent, benefiting from its bioinformatics workflow solutions, genomic data interpretation platforms, and strong presence in molecular diagnostics and translational research.

Agilent Technologies represents 11.8 percent, leveraging its expertise in analytical instruments, genomic software tools, and bioinformatics solutions supporting omics research and drug discovery.

PerkinElmer holds 8.9 percent, driven by its bioinformatics and data analytics platforms for life sciences, diagnostics, and pharmaceutical research environments.

Dassault Systèmes accounts for 6.7 percent, supported by its BIOVIA platform offering advanced modeling, simulation, and data management solutions for biological and pharmaceutical research.

Celera Corporation represents 4.3 percent, with continued relevance through proprietary genomic databases and bioinformatics resources supporting research and biomarker discovery.

Data4Cure holds 2.3 percent, focusing on cloud-based bioinformatics platforms for data integration, visualization, and translational medicine applications.

Geneva Bioinformatics SA captures 1.8 percent, driven by specialized genomic analysis services and bioinformatics consulting for academic and clinical research institutions.

Lineage Cell Therapeutics accounts for 0.9 percent, contributing through bioinformatics-supported cell therapy research and data-driven regenerative medicine development.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=bioinformatics-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Rising adoption of genomics, proteomics, transcriptomics, and metabolomics in biomedical research and clinical applications.

- Growing demand for data-driven insights in drug discovery, precision medicine, and personalized healthcare.

- Rapid increase in biological data generated from next-generation sequencing (NGS), microarrays, and high-throughput technologies.

- Advancements in AI, machine learning, and big data analytics improving biological data interpretation and prediction accuracy.

- Expanding use of bioinformatics in cancer research, rare disease diagnosis, and infectious disease surveillance.

- Supportive government funding and academic-industry collaborations in life sciences research.

- Increasing need to reduce drug development time and costs through in-silico modeling and simulation.

Industry Developments
- Launch of advanced bioinformatics platforms for multi-omics data integration and analysis.

- Development of cloud-based bioinformatics solutions enabling scalable storage and real-time collaboration.

- Integration of AI-powered tools for gene annotation, variant interpretation, and protein structure prediction.

- Growing partnerships between biotechnology companies, pharmaceutical firms, and bioinformatics software providers.

- Expansion of bioinformatics applications in clinical diagnostics and companion diagnostics.

- Increased investments, mergers, and acquisitions in bioinformatics software and service providers.

- Enhancement of data visualization, workflow automation, and interoperability capabilities.

Regional Insights
North America - 41% share: "Driven by strong genomics research infrastructure, high R&D spending, widespread adoption of precision medicine, and presence of leading biotech and pharma companies."

Europe - 29% share: "Supported by robust academic research networks, government-funded genomics initiatives, and growing integration of bioinformatics in clinical research."

Asia Pacific - 25% share: "Fueled by expanding genomics programs, rising biotech investments, increasing research output, and rapid adoption of advanced computational tools."

Latin America - 3% share: "Boosted by growing life sciences research activities, improving research infrastructure, and increasing collaborations with global institutions."

Middle East & Africa - 2% share: "Driven by emerging genomics initiatives, healthcare modernization efforts, and gradual adoption of bioinformatics solutions."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioinformatics-market?sai-v

Key Segments

By Product & Services Type
Bioinformatics platforms dominate the market as they provide integrated environments for data storage, analysis, visualization, and interpretation of large and complex biological datasets. Knowledge management tools hold a significant share, driven by the growing need to organize, curate, and retrieve biological and clinical data efficiently across research and healthcare institutions. Services are witnessing strong growth as organizations increasingly outsource data analysis, pipeline development, system integration, and consulting to manage complexity, reduce costs, and accelerate research timelines.

By Application
Genomics represents the largest application segment, supported by the rapid adoption of next-generation sequencing technologies and increasing demand for genomic data analysis. Gene engineering is gaining traction with the expansion of CRISPR and other gene-editing technologies in research and therapeutic development. Drug development holds a substantial share, as bioinformatics tools are increasingly used for target identification, lead optimization, and clinical trial analysis. Omics applications, including proteomics, transcriptomics, and metabolomics, continue to expand due to advances in multi-omics research and systems biology. Personalized medicine is one of the fastest-growing segments, driven by the shift toward precision healthcare and data-driven treatment decisions. Other applications, such as agricultural biotechnology and microbial research, contribute steadily to overall market growth.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.